Cogent Biosciences Inc (NASDAQ: COGT) started the day on Wednesday, with a price increase of 7.11% at $37.79, before settling in for the price of $35.28 at the close. Taking a more long-term approach, COGT posted a 52-week range of $3.72-$43.73.
It was noted that the giant of the Healthcare sector posted annual sales growth of 10.02% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 10.02%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.29%. This publicly-traded company’s shares outstanding now amounts to $139.83 million, simultaneously with a float of $123.92 million. The organization now has a market capitalization sitting at $5.75 billion.
Cogent Biosciences Inc (COGT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Cogent Biosciences Inc’s current insider ownership accounts for 18.50%, in contrast to 87.61% institutional ownership. According to the most recent insider trade that took place on Dec 26 ’25, this organization’s Chief Legal Officer sold 65,000 shares at the rate of 38.70, making the entire transaction reach 2,515,500 in total value, affecting insider ownership by 109,398. Preceding that transaction, on Dec 26 ’25, Company’s Chief Financial Officer sold 77,000 for 38.68, making the whole transaction’s value amount to 2,978,360. This particular insider is now the holder of 131,834 in total.
Cogent Biosciences Inc (COGT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
Cogent Biosciences Inc’s EPS increase for this current 12-month fiscal period is 9.29% and is forecasted to reach -1.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 44.34% through the next 5 years, which can be compared against the 10.02% growth it accomplished over the previous five years trading on the market.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Let’s observe the current performance indicators for Cogent Biosciences Inc (COGT). It’s Quick Ratio in the last reported quarter now stands at 6.38.
In the same vein, COGT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.37, a figure that is expected to reach -0.51 in the next quarter, and analysts are predicting that it will be -1.78 at the market close of one year from today.
